
The global biopharmaceutical sector stands at a critical crossroads where scientific breakthroughs in gene editing and personalized medicine are outpacing the traditional frameworks used to manage human capital. To address these widening gaps, top human resources executives from global pharmaceutical giants and agile biotech startups recently convened to examine how talent management must fundamentally evolve to sustain this momentum. This










